Although the IgG2 isotype of anti-TIF1γ has been shown to be a biomarker for malignancy and mortality in adult DM, there was no report of malignancy in this paediatric cohort (Supplementary Table S1, available at Rheumatology online ). This evidence concerns the gene TRIM33 and dermatomyositis.